{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:51:50Z","timestamp":1793224310189,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01180-y","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:28:10Z","timestamp":1773916090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CircBARD1 suppresses tumor progression driven by H3K18 lactylation-CCNA2 axis in human bladder cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Zhenghui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"1180_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"L. Dyrskj\u00f8t et al., Bladder cancer. Nat. Rev. Dis. Primers. 9, 58 (2023). https:\/\/doi.org\/10.1038\/s41572-023-00468-9","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1180_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"A.T. Lenis, P.M. Lec, K. Chamie, M.D. Mshs, Bladder Cancer: Rev. Jama. 324, 1980\u20131991 (2020). https:\/\/doi.org\/10.1001\/jama.2020.17598","journal-title":"Bladder Cancer: Rev. Jama"},{"key":"1180_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00963-y","author":"M Leyderman","year":"2024","unstructured":"M. Leyderman et al., Metastasis development in non-muscle-invasive bladder cancer. Nat. Rev. Urol. (2024). https:\/\/doi.org\/10.1038\/s41585-024-00963-y","journal-title":"Nat. Rev. Urol."},{"key":"1180_CR4","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"A. Lopez-Beltran, M.S. Cookson, B.J. Guercio, L. Cheng, Advances in diagnosis and treatment of bladder cancer. Bmj. 384, e076743 (2024). https:\/\/doi.org\/10.1136\/bmj-2023-076743","journal-title":"Bmj"},{"key":"1180_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-022-01582-0","volume":"21","author":"C Xue","year":"2022","unstructured":"C. Xue et al., The functional roles of the circRNA\/Wnt axis in cancer. Mol. Cancer. 21, 108 (2022). https:\/\/doi.org\/10.1186\/s12943-022-01582-0","journal-title":"Mol. Cancer"},{"key":"1180_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"L.S. Kristensen et al., The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 20, 675\u2013691 (2019). https:\/\/doi.org\/10.1038\/s41576-019-0158-7","journal-title":"Nat. Rev. Genet."},{"key":"1180_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","volume":"16","author":"F Zhang","year":"2023","unstructured":"F. Zhang, J. Jiang, H. Qian, Y. Yan, W. Xu, Exosomal circrna: emerging insights into cancer progression and clinical application potential. J. Hematol. Oncol. 16, 67 (2023). https:\/\/doi.org\/10.1186\/s13045-023-01452-2","journal-title":"J. Hematol. Oncol."},{"key":"1180_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-023-01766-2","volume":"22","author":"ZH Zhang","year":"2023","unstructured":"Z.H. Zhang et al., The function and mechanisms of action of circular RNAs in urologic cancer. Mol. Cancer. 22, 61 (2023). https:\/\/doi.org\/10.1186\/s12943-023-01766-2","journal-title":"Mol. Cancer"},{"key":"1180_CR9","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.7150\/ijbs.84994","volume":"19","author":"W Chen","year":"2023","unstructured":"W. Chen et al., The potential role and mechanism of circRNA\/miRNA axis in cholesterol synthesis. Int. J. Biol. Sci. 19, 2879\u20132896 (2023). https:\/\/doi.org\/10.7150\/ijbs.84994","journal-title":"Int. J. Biol. Sci."},{"key":"1180_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"V.M. Conn, A.M. Chinnaiyan, S.J. Conn, Circular RNA in cancer. Nat. Rev. Cancer. 24, 597\u2013613 (2024). https:\/\/doi.org\/10.1038\/s41568-024-00721-7","journal-title":"Nat. Rev. Cancer"},{"key":"1180_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.omtn.2020.10.003","volume":"22","author":"F Wang","year":"2020","unstructured":"F. Wang et al., Circular RNA circRIMS1 acts as a sponge of miR-433-3p to promote bladder cancer progression by regulating CCAR1 expression. Mol. Ther. Nucleic Acids. 22, 815\u2013831 (2020). https:\/\/doi.org\/10.1016\/j.omtn.2020.10.003","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1180_CR12","doi-asserted-by":"publisher","first-page":"704683","DOI":"10.3389\/fcell.2021.704683","volume":"9","author":"F Wang","year":"2021","unstructured":"F. Wang et al., Circular RNA CircPPP1CB suppresses tumorigenesis by interacting with the MiR-1307-3p\/SMG1 axis in human bladder cancer. Front. Cell. Dev. Biol. 9, 704683 (2021). https:\/\/doi.org\/10.3389\/fcell.2021.704683","journal-title":"Front. Cell. Dev. Biol."},{"key":"1180_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41467-024-55577-0","volume":"16","author":"T Lan","year":"2025","unstructured":"T. Lan et al., The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat. Commun. 16, 333 (2025). https:\/\/doi.org\/10.1038\/s41467-024-55577-0","journal-title":"Nat. Commun."},{"key":"1180_CR14","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1158\/0008-5472.Can-23-3596","volume":"84","author":"Z Rong","year":"2024","unstructured":"Z. Rong et al., CircRREB1 mediates metabolic reprogramming and stemness maintenance to facilitate pancreatic ductal adenocarcinoma progression. Cancer Res. 84, 4246\u20134263 (2024). https:\/\/doi.org\/10.1158\/0008-5472.Can-23-3596","journal-title":"Cancer Res."},{"key":"1180_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omto.2021.12.026","volume":"24","author":"CK Huang","year":"2022","unstructured":"C.K. Huang, Y. Sun, L. Lv, Y. Ping, ENO1 and cancer. Mol. Ther. Oncolytics. 24, 288\u2013298 (2022). https:\/\/doi.org\/10.1016\/j.omto.2021.12.026","journal-title":"Mol. Ther. Oncolytics"},{"key":"1180_CR16","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1158\/0008-5472.Can-20-3543","volume":"81","author":"HJ Li","year":"2021","unstructured":"H.J. Li et al., ENO1 promotes lung cancer metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal transition. Cancer Res. 81, 4094\u20134109 (2021). https:\/\/doi.org\/10.1158\/0008-5472.Can-20-3543","journal-title":"Cancer Res."},{"key":"1180_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","volume":"3","author":"T Zhang","year":"2022","unstructured":"T. Zhang et al., ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat. Cancer. 3, 75\u201389 (2022). https:\/\/doi.org\/10.1038\/s43018-021-00299-1","journal-title":"Nat. Cancer"},{"key":"1180_CR18","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.7150\/ijbs.90774","volume":"20","author":"X Xu","year":"2024","unstructured":"X. Xu et al., USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic Glycolysis and proliferation in cholangiocarcinoma. Int. J. Biol. Sci. 20, 1492\u20131508 (2024). https:\/\/doi.org\/10.7150\/ijbs.90774","journal-title":"Int. J. Biol. Sci."},{"key":"1180_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"D. Zhang et al., Metabolic regulation of gene expression by histone lactylation. Nature. 574, 575\u2013580 (2019). https:\/\/doi.org\/10.1038\/s41586-019-1678-1","journal-title":"Nature"},{"key":"1180_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"J. Yu et al., Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 22, 85 (2021). https:\/\/doi.org\/10.1186\/s13059-021-02308-z","journal-title":"Genome Biol."},{"key":"1180_CR21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"R.Y. Pan et al., Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in alzheimer\u2019s disease. Cell. Metab. 34, 634\u2013648e636 (2022). https:\/\/doi.org\/10.1016\/j.cmet.2022.02.013","journal-title":"Cell. Metab."},{"key":"1180_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-023-01856-1","volume":"22","author":"B Xie","year":"2023","unstructured":"B. Xie et al., CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol. Cancer. 22, 151 (2023). https:\/\/doi.org\/10.1186\/s12943-023-01856-1","journal-title":"Mol. Cancer"},{"key":"1180_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"W. Li et al., Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 20, 114\u2013130 (2024). https:\/\/doi.org\/10.1080\/15548627.2023.2249762","journal-title":"Autophagy"},{"key":"1180_CR24","doi-asserted-by":"publisher","unstructured":"A. Fukushi, H.D. Kim, Y.C. Chang, C.H. Kim, Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells. Int. J. Mol. Sci. 23 (2022). https:\/\/doi.org\/10.3390\/ijms231710037","DOI":"10.3390\/ijms231710037"},{"key":"1180_CR25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/labinvest.2015.71","volume":"95","author":"P Zhan","year":"2015","unstructured":"P. Zhan et al., FBXW7 negatively regulates ENO1 expression and function in colorectal cancer. Lab. Invest. 95, 995\u20131004 (2015). https:\/\/doi.org\/10.1038\/labinvest.2015.71","journal-title":"Lab. Invest."},{"key":"1180_CR26","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.7150\/thno.54961","volume":"11","author":"T Deng","year":"2021","unstructured":"T. Deng et al., CCDC65 as a new potential tumor suppressor induced by Metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics. 11, 8112\u20138128 (2021). https:\/\/doi.org\/10.7150\/thno.54961","journal-title":"Theranostics"},{"key":"1180_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"L.S. Kristensen, T. Jakobsen, H. Hager, J. Kjems, The emerging roles of circrnas in cancer and oncology. Nat. Rev. Clin. Oncol. 19, 188\u2013206 (2022). https:\/\/doi.org\/10.1038\/s41571-021-00585-y","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1180_CR28","doi-asserted-by":"publisher","first-page":"136719","DOI":"10.1016\/j.jhazmat.2024.136719","volume":"484","author":"HX Zeng","year":"2024","unstructured":"H.X. Zeng et al., Circular RNA circ_0061183 regulates microglial polarization induced by airborne ultrafine particles in HMC3 cells via sponging miR-98-5p. J. Hazard. Mater. 484, 136719 (2024). https:\/\/doi.org\/10.1016\/j.jhazmat.2024.136719","journal-title":"J. Hazard. Mater."},{"key":"1180_CR29","doi-asserted-by":"publisher","first-page":"111510","DOI":"10.1016\/j.cellsig.2024.111510","volume":"125","author":"X Shu","year":"2025","unstructured":"X. Shu et al., N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1\/PCNA axis. Cell. Signal. 125, 111510 (2025). https:\/\/doi.org\/10.1016\/j.cellsig.2024.111510","journal-title":"Cell. Signal."},{"key":"1180_CR30","doi-asserted-by":"publisher","unstructured":"M. Zhang et al., circSIRT2\/miR-542-3p\/VASH1 axis regulates endothelial-to-mesenchymal transition (EndMT) in subretinal fibrosis in age-related macular degeneration models. Aging. Cell. e14443. https:\/\/doi.org\/10.1111\/acel.14443 (2025)","DOI":"10.1111\/acel.14443"},{"key":"1180_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12943-025-02500-w","volume":"24","author":"H Chen","year":"2025","unstructured":"H. Chen et al., A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia. Mol. Cancer. 24, 285 (2025). https:\/\/doi.org\/10.1186\/s12943-025-02500-w","journal-title":"Mol. Cancer"},{"key":"1180_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.09.053","author":"Y Yang","year":"2025","unstructured":"Y. Yang et al., CircCDYL promotes Glycolysis to drive the progression of nasopharyngeal carcinoma. J. Adv. Res. (2025). https:\/\/doi.org\/10.1016\/j.jare.2025.09.053","journal-title":"J. Adv. Res."},{"key":"1180_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13046-025-03355-1","volume":"44","author":"AC Palcau","year":"2025","unstructured":"A.C. Palcau et al., CircPVT1 weakens miR-33a-5p unleashing the c-MYC\/GLS1 metabolic axis in breast cancer. J. Exp. Clin. Cancer Res. 44, 100 (2025). https:\/\/doi.org\/10.1186\/s13046-025-03355-1","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1180_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-024-02203-8","volume":"24","author":"C Can","year":"2025","unstructured":"C. Can et al., Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity. Mol. Cancer. 24, 4 (2025). https:\/\/doi.org\/10.1186\/s12943-024-02203-8","journal-title":"Mol. Cancer"},{"key":"1180_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02122-8","volume":"24","author":"Y Wang","year":"2025","unstructured":"Y. Wang et al., circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Mol. Cancer. 24, 1 (2025). https:\/\/doi.org\/10.1186\/s12943-024-02122-8","journal-title":"Mol. Cancer"},{"key":"1180_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.apsb.2022.05.019","volume":"13","author":"M Sun","year":"2023","unstructured":"M. Sun et al., PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD\/ENO1 mediated cell metabolism. Acta Pharm. Sin B 13, 157\u2013173 (2023). https:\/\/doi.org\/10.1016\/j.apsb.2022.05.019","journal-title":"Acta Pharm. Sin B"},{"key":"1180_CR37","doi-asserted-by":"publisher","unstructured":"X. Wei et al., METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1. Cancer Lett. 217194 (2024). https:\/\/doi.org\/10.1016\/j.canlet.2024.217194","DOI":"10.1016\/j.canlet.2024.217194"},{"key":"1180_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","volume":"20","author":"EM Michalak","year":"2019","unstructured":"E.M. Michalak, M.L. Burr, A.J. Bannister, M.A. Dawson, The roles of DNA, RNA and histone methylation in ageing and cancer. Nat. Rev. Mol. Cell. Biol. 20, 573\u2013589 (2019). https:\/\/doi.org\/10.1038\/s41580-019-0143-1","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"1180_CR39","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.7150\/thno.73223","volume":"12","author":"Q Chen","year":"2022","unstructured":"Q. Chen et al., Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents. Theranostics. 12, 4935\u20134948 (2022). https:\/\/doi.org\/10.7150\/thno.73223","journal-title":"Theranostics"},{"key":"1180_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.semcancer.2022.07.003","volume":"86","author":"G Bononi","year":"2022","unstructured":"G. Bononi et al., Historical perspective of tumor glycolysis: A century with Otto Warburg. Semin Cancer Biol. 86, 325\u2013333 (2022). https:\/\/doi.org\/10.1016\/j.semcancer.2022.07.003","journal-title":"Semin Cancer Biol."},{"key":"1180_CR41","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"F. Li et al., Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist. Updat. 73, 101059 (2024). https:\/\/doi.org\/10.1016\/j.drup.2024.101059","journal-title":"Drug Resist. Updat"},{"key":"1180_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tig.2021.09.009","volume":"38","author":"X Dai","year":"2022","unstructured":"X. Dai, X. Lv, E.W. Thompson, K.K. Ostrikov, Histone lactylation: epigenetic mark of glycolytic switch. Trends Genet. 38, 124\u2013127 (2022). https:\/\/doi.org\/10.1016\/j.tig.2021.09.009","journal-title":"Trends Genet."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01180-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:28:10Z","timestamp":1773916090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01180-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01180-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7337848\/v1","asserted-by":"object"}]},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine for the utilization of clinical samples with patient consent as well as for the xenograft tumorigenesis model. All operations and experimental protocols were carried out as per NIH laboratory instructions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This work has been accepted for publication by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}